+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Physician Dispensed Cosmeceuticals - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 515 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 2228061

Global Physician Dispensed Cosmeceuticals Market to Reach $28.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Physician Dispensed Cosmeceuticals estimated at US$15.7 Billion in the year 2020, is projected to reach a revised size of US$28.3 Billion by 2027, growing at a CAGR of 8.7% over the period 2020-2027. Skin Care, one of the segments analyzed in the report, is projected to record a 9.9% CAGR and reach US$12.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hair Care segment is readjusted to a revised 8.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $5.9 Billion, While China is Forecast to Grow at 10.9% CAGR

The Physician Dispensed Cosmeceuticals market in the U.S. is estimated at US$5.9 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2027 trailing a CAGR of 10.9% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 7.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.9 Billion by the year 2027.

Eye Care Segment to Record 8% CAGR

In the global Eye Care segment, USA, Canada, Japan, China and Europe will drive the 8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.2 Billion in the year 2020 will reach a projected size of US$3.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 8.8% CAGR through the analysis period.

Select Competitors (Total 120 Featured)

  • Allergan Plc
  • SkinMedica, Inc.
  • Biopelle, Inc.
  • Clinique Laboratories, LLC
  • Cutera, Inc.
  • Emerson Ecologics, LLC
  • iS CLINICAL
  • Jan Marini Skin Research, Inc.
  • La Roche-Posay Laboratoire Pharmaceutique
  • Neutrogena Corp.
  • Obagi Medical Products, Inc.
  • SkinCeuticals
  • Stiefel Laboratories, Inc.

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to a digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Physician Dispensed Cosmeceuticals

What is the estimated value of the Global Market for Physician Dispensed Cosmeceuticals?

The Global Market for Physician Dispensed Cosmeceuticals was estimated to be valued at $15.7 Billion in 2020.

What is the growth rate of the Global Market for Physician Dispensed Cosmeceuticals?

The growth rate of the Global Market for Physician Dispensed Cosmeceuticals is 8.8%, with an estimated value of $28.3 Billion by 2027.

What is the forecasted size of the Global Market for Physician Dispensed Cosmeceuticals?

The Global Market for Physician Dispensed Cosmeceuticals is estimated to be worth $28.3 Billion by 2027.

Who are the key companies in the Global Market for Physician Dispensed Cosmeceuticals?

Key companies in the Global Market for Physician Dispensed Cosmeceuticals include Allergan Plc, SkinMedica, Inc., Biopelle, Inc., Clinique Laboratories, LLC, Cutera, Inc., Emerson Ecologics, LLC, iS CLINICAL, Jan Marini Skin Research, Inc. and Posay Laboratoire Pharmaceutique.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Impact of COVID-19 Pandemic and Looming Global Recession
  • Exhibit 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • The Global Beauty Industry Recovers Cautiously from the Pandemic Impact
  • Exhibit 2: Global Beauty Sector Percentage YoY Growth: 2016 to 2024
  • Dermatology Practices amid the Pandemic
  • A Peek into Future Skincare Trends
  • Beauty-from-Within Trend Scripts Inventive Plays for Cosmeceuticals & Delivery Formats
  • Competition
  • Exhibit 3: Physician Dispensed Cosmeceuticals - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • An Introduction to Physician-Dispensed Cosmeceuticals
  • Types of Physician-Dispensed Cosmeceuticals
  • Select Major Ingredients Used in Physician-Dispensed Cosmeceuticals
  • Physician Dispensed Cosmeceuticals: Delivering Health and Beauty
  • Global Market Prospects & Outlook
  • Physician-Dispensed Skin Care Products Lead the Global Market
  • Developed Regions Lead, Developing Economies to Spearhead Future Growth
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Myriad Benefits of Physician Dispensing of Cosmeceuticals Drives Market Growth
  • Growth in the Global Cosmeceuticals Market Bodes Well for Physician-Dispensed Products
  • Aging Population Emerges as a Key Demographic Driver of Growth in the Physician-Dispensed Cosmeceuticals Market
  • Exhibit 4: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Exhibit 5: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Societal Pressure to Look Young Peps Demand for Facial Aesthetics
  • Undesirable Side Effects: A Challenge to Reckon With
  • Anti-Aging Products: The Prime Category in the Physician-Dispensed Cosmeceuticals Market
  • Exhibit 6: Global Anti-Aging Cosmetics Market for the Years 2017, 2019, 2021, 2023 and 2025
  • Major Anti-Aging Ingredients of Cosmeceuticals
  • Cosmeceuticals with Biologically Active Ingredients to Improve Skin Functioning Begin to Find Favor
  • Increased Focus on Skin Microbiome Paves Way for New Generation Skincare Products
  • Cosmeceuticals Receive Boost from Introduction of Lipid Nanoparticles
  • Skin Brightening and Lightening Products: Significant Opportunities for Growth
  • Stem Cell Products Transform Market
  • Select Popular Stem Cell Beauty Products
  • Botulinum Toxin: The Preferred Solution in Facial Injectables Market
  • Exhibit 7: Cosmetic Botulinum Toxin Procedures Performed Worldwide: Percentage Breakdown of Procedure Volume by Gender for 2020E
  • Factors Propelling the Cosmetic Botox Market: In a Nut Shell
  • Millennials: A Popular Demographic Group for Botulinum Toxin
  • Exhibit 8: Cosmetic Botulinum Toxin Procedures Performed Worldwide: Percentage Breakdown of Procedure Volume by Age Group for 2019
  • Cosmeceutical Consumers: A Highly Informed, Aesthetically-Conscious Group
  • Rise in Young Population and Skin Conditions Such as Acne Drive Demand
  • Women Account for Highest Spends on Skin Care
  • Exhibit 9: Women as % of Total Labor Force in Select Countries: 2019
  • Growing Trend towards Cosmeceuticals with Natural Ingredients
  • Focus on Finding Alternatives to Hydroquinone for Pigment Control Purposes
  • Manufacturers Widen Customer Base
  • Physician Dispensing of Cosmeceuticals Remains a Contentious Topic
  • Distribution Scenario
  • E-Commerce Channels Reinforce Sales of Physician Dispensed Products
  • Exhibit 10: Percentage Share of Online Channel in Health and Beauty Sector: 2020 and 2025
  • Social Networking Emerges as an Effective Marketing Tool in the Beauty Space
  • An Insight into Notable Barriers to Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Physician Dispensed Cosmeceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Physician Dispensed Cosmeceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Physician Dispensed Cosmeceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for Skin Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Skin Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Skin Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 7: World Recent Past, Current & Future Analysis for Hair Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Hair Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Hair Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for Eye Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Eye Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Eye Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 13: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 16: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 19: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 22: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • Physician Dispensed Cosmeceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • United States: A Major Market for Physician Dispensed Cosmeceuticals
  • Anti-Aging Cosmeceuticals and Sunscreens to Drive Growth
  • Baby-Boomers and Working Females Propel Demand for Skin Care Products
  • Exhibit 11: US Population by Age Group: Percentage Breakdown of Population by Age Group (2020)
  • Exhibit 12: North American Aging Population by Age Group: 1975-2050
  • Increasing Demand for Cosmetic Treatments Augurs Well for the Market
  • Hydroquinone-free Products Attract Attention
  • Market Analytics
CANADA
  • Anti-Aging Cosmeceutical Products: Market Overview
  • Market Analytics
JAPAN
  • Market Overview
  • Market Analytics
CHINA
  • Market Overview
  • Aging Population Fuels Market Prospects
  • Market Analytics
EUROPE
  • Physician Dispensed Cosmeceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Market Overview
  • Market Analytics
FRANCEGERMANYITALYUNITED KINGDOMSPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Market Overview
  • Market Analytics
AUSTRALIA
INDIA
  • Market Overview
  • Market Analytics
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Market Overview
  • Market Analytics
ARGENTINA
BRAZIL
  • Market Overview
  • Market Analytics
MEXICOREST OF LATIN AMERICAMIDDLE EASTIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTAFRICA
IV. COMPETITION
  • Total Companies Profiled: 120

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allergan Plc
  • SkinMedica, Inc.
  • Biopelle, Inc.
  • Clinique Laboratories, LLC
  • Cutera, Inc.
  • Emerson Ecologics, LLC
  • iS CLINICAL
  • Jan Marini Skin Research, Inc.
  • La Roche-Posay Laboratoire Pharmaceutique
  • Neutrogena Corp.
  • Obagi Medical Products, Inc.
  • SkinCeuticals
  • Stiefel Laboratories, Inc.